BioSight
Companies
Vericel Corp logo

VCEL

NASDAQCAMBRIDGE, MA
Vericel Corp

Vericel manufactures cell therapy products for orthopedic and wound care applications, including MACI and MACI Arthro for cartilage defects, Epicel for severe burns, and NexoBrid for burn wounds. The company has commercialized products on the market and is pursuing FDA approval for additional indications, such as MACI for ankle cartilage defects. Vericel is focused on scaling manufacturing capacity to meet demand for its existing cell therapy products while advancing their regulatory and commercial development.

Price history not yet available for VCEL.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar